Protocol for the examination of specimens from patients with invasive carcinoma of the breast.

Authors Susan C. Lester, MD, PhD, FCAP* Department of Pathology, Brigham and Women’s Hospital, Boston, Massachusetts Shikha Bose, MD, FCAP Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California Yunn-Yi Chen, MD, PhD, FCAP Department of Pathology, UCSF Medical Center, San Francisco, California James L. Connolly, MD, FCAP Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts Monica E. de Baca, MD, FCAP, FASCP Pathology Associates of Kitsap County, Bremerton, Washington Patrick L. Fitzgibbons, MD, FCAP Department of Pathology, St. Jude Medical Center, Fullerton, California Daniel F. Hayes, MD, Department of Medical Oncology, University of Michigan Medical Center, Ann Arbor, Michigan Kalisha A. Hill, MD, FCAP, FASCP Department of Pathology and Clinical Laboratory, St. James Hospital – Olympia Fields, Olympia Fields, Illinois Celina Kleer, MD, FCAP Department of Pathology, University of Michigan Medical Center, Ann Arbor, Michigan Frances P. O’Malley, MD, FCAP Department of Laboratory Medicine, St. Michael’s Hospital and University of Toronto, Toronto, Ontario David L. Page, MD, FCAP Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee Barbara L. Smith, MD, PhD Department of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts Lee K. Tan, MD Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York Donald L. Weaver, MD, FCAP Department of Pathology, College of Medicine and Vermont Cancer Center, University of Vermont, Burlington, Vermont Eric Winer, MD Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts Jean F. Simpson, MD, FCAP† Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee For the Members of the Cancer Committee, College of American Pathologists